Gadolinium-binding helix-turn-helix peptides: DNA-dependent MRI contrast agents.

Chem Commun (Camb)

EPIX Medical, Inc., 71 Rogers Street, Cambridge, MA 02142, USA.

Published: October 2003

A de novo designed gadolinium metallopeptide was found to be a very efficient relaxation agent, with 100% increase in relaxivity upon binding to DNA.

Download full-text PDF

Source
http://dx.doi.org/10.1039/b307817eDOI Listing

Publication Analysis

Top Keywords

gadolinium-binding helix-turn-helix
4
helix-turn-helix peptides
4
peptides dna-dependent
4
dna-dependent mri
4
mri contrast
4
contrast agents
4
agents novo
4
novo designed
4
designed gadolinium
4
gadolinium metallopeptide
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!